A. Montag and Associates »

Arrivent Biopharma shares owned by A. Montag and Associates

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by A. Montag and Associates from 13F filings

Historical chart of A. Montag and Associates investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by A. Montag and Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by A. Montag and Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $202 11 18.45

More positions owned by A. Montag and Associates

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Rus 1000 Etf (IWB)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Home Depot (HD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Specialized Funds Div App Etf (VIG)
Broadcom Call Call Option (Principal) (AVGO)

View all positions for A. Montag and Associates

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
Infinitum Asset Management
Suvretta Capital Management
FMR
OrbiMed Advisors
BlackRock
Vanguard Group
Octagon Capital Advisors
Novo A/S
Sofinnova Ventures
General Catalyst Group Management
State Street Corporation
Geode Capital Management
Siren
Sc China Holding

View all funds holding Arrivent Biopharma